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Aim: Although the Pap smear is a common screening test for cervical cancer and its precursors, it can detect some benign conditions
as well. In this study, the aim was to evaluate smear results with regard to nonneoplastic findings and to compare them to the detectable
effects of intrauterine devices (IUDs) and oral contraceptive pills (OPs).
Materials and methods: In this retrospective study, the hospital records and cytopathology reports of 4248 patients were recorded.
Smear results were evaluated according to the 2001 Bethesda System and were evaluated according to age groups, menopausal/menstrual
status, physical examination findings, and contraceptive method usage.
Results: Of the 4248 patients, 75% were menstruating and 25% were menopausal. The most common smear result was nonspecific
inflammation (NSI). In comparing the IUD (n = 730) and OP (n = 322) groups, we found Candida species, Actinomyces, and bacterial
vaginosis to be significantly higher in the IUD-using group, while NSI, discharge, and erosion were found to be significantly higher in
the OP group.
Conclusion: Pap smears can provide information about infectious diseases that can occur in the cervicovaginal region. These results
reflect the fact that the IUDs disrupt vaginal flora more than OPs do.
Key words: Smear, oral contraceptive pill, intrauterine device, erosion, discharge

1. Introduction
The Pap smear is a screening test carried out by spreading
cells taken from the inner and outer part of the uterine
cervix on a glass slide. It was developed by George
Papanicolaou in 1943 and is named after him. It is a
simple, rapid, and painless procedure performed during
speculum examination by clinicians. Cells are obtained,
placed on a glass slide, rinsed with liquid fixative, and sent
to a pathology laboratory for examination (1–5).
Although the Pap smear is a common screening test
for cervical cancer and its precursors, it can detect some
benign conditions, as well (1,6). In the present study,
4248 smear results were reviewed in order to determine
their relation with age, menopausal status, contraceptive
history, and physical examination findings.
2. Materials and methods
In this retrospective study, the hospital records and
cytopathology reports of 4248 women who were referred
* Correspondence: drbedir75@yahoo.com

to the Department of Gynecology and Obstetrics at
Keçiören Education and Research Hospital between
September 2006 and September 2009 were examined.
Smears were taken from the internal and outer surfaces
of the cervix using a brush and were spread on a glass
slide. They were fixated with alcohol to protect cells from
harm and were sent to a pathology laboratory. Slides were
stained using the Papanicolaou (Pap) technique and were
evaluated according to the 2001 Bethesda standards as
formerly described (7). Results were classified as normal
smear (NS), nonspecific inflammation (NSI), Candida
species (CS), shift of flora suggestive of bacterial vaginosis
(BV), Trichomonas vaginalis (TV), Actinomyces species
(AS), atrophic vaginitis (AV), and atypia of undetermined
significance (ASC-US).
The patient’s age, menstruation or menopausal status,
physical examination findings (erosion and discharge),
and contraception method used, if any, were all recorded.
Contraceptive methods noted were intrauterine
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contraceptive devices (IUDs) and oral contraceptive
pills (OPs). Patients were divided into 4 age groups for
statistical analysis: 0–20 years, 21–40 years, 41–50 years,
and over 51 years.
Results were expressed by frequency analysis. The
significance of intergroup differences was studied with
SPSS 16.0 (SPSS Inc., Chicago, IL, USA) by chi-square test.
P < 0.05 was considered statistically significant.
3. Results
Of the 4248 patients, 3188 (75%) were menstruating and
1060 (25%) were menopausal. Smear results were found
as follows: 12% were NS (n = 511), 65.1% were NSI (n =
2766), 5.1% were CS (n = 218), 5.6% were BV (n = 237),
1.4% were TV (n = 57), 0.09% were AS (n = 38), 9% were
AV (n = 383), and 0.8% were ASC-US (n = 24).
Smear results according to age groups are shown in
Table 1. The corresponding results in menopausal and
menstruating patients are shown in Table 2.
As a result of contraceptive method analysis, it was
found that 17.2% of the patients used an IUD and 7.8% used
OPs. The rates of NSI were 71% and 81% among those who
used IUDs and OPs, respectively. The difference between
the IUD and OP groups was found to be statistically
significant. The rates of AS were 4% and 0% in those
who used IUDs and OPs, respectively, with a statistically
significant difference. The rate of BV was 7% and 2.7% in
the IUD and OP groups, respectively, with a statistically
significant difference. The rate of CS was 7.3% in those
using IUDs, while it was 3.9% in those who used OPs. The
difference was statistically significant. The rate of NS was
7% in the IUD group, while it was 9.6% in the OP group,
with a statistically significant difference between groups.
The rates of AV, TV, and ASC-US were not statistically
significant between the 2 groups. Discharge was present in
56% of the patients using IUDs and 68.9% of those using

OPs, with a significant difference between them. Erosion
was found in 6.7% of those using IUDs and 7.5% of those
using OPs, with a statistically significant difference (Table
3).
4. Discussion
The Pap smear is a screening test that can be carried out
readily during gynecological examination. It should be
conducted once a year in women of reproductive age (1).
Although the Pap smear was developed for cervical cancer
screening, it is obvious that it sheds light on nonneoplastic
pathologies, as well (1,6) .
In this community-based study carried out with quite
a large sample, it can be observed that ASC-US occurred
at low rates in smear results, and nonneoplastic findings
were detected far more commonly. ASC-US reflects a
pathological diagnosis rather than a clinical diagnosis and
patient follow-up is necessary. Our ASC-US rates (0.8%)
were lower than those rates in the previous literature
from Turkey, which reported an overall rate of 1.07%, but
in reality our rates were similar to some of the individual
participant hospitals’ rates (0.6%, 0.7%) from that study (8).
In the evaluation of all smear results, it was seen
that NSI was the leading result, followed by NS and AV,
which were expected to be high in menopausal women.
Following them, BV, CS, TV, AS, and ASC-US were found
in decreasing order of frequency. The high rate of NSI is
compatible with the results of previous studies. This shows
that there is cervical inflammation in the majority of
women in the community, even if it is not specific (1).
In the evaluation of age groups, NSI is most common
in the age group of 20–40 years, followed by 41–50 years,
0–20 years, and over 50 years. It can be concluded from
these results that NSI occurs mostly in women of childbearing age. NSI occurs less frequently in women over 50,
suggesting that in sexually active women of reproductive

Table 1. The distribution of nonneoplastic smear results according to age (frequency analysis; percentage (number)).
Characteristics

N

NSI

BV

CS

AS

TV

AV

ASC-US

Age 0–20
2.3% (99)

24.2%
(24)

65.7%
(65)

3%
(3)

5.1%
(5)

0%
(0)

1%
(1)

0%
(0)

1%
(1)

Age 21–40
49.1% (2084)

10.8%
(226)

72.7%
(1515)

6.2%
(130)

7%
(146)

1%
(20)

1.1%
(22)

0.3%
(7)

0.8%
(17)

Age 41–50
28.8% (1223)

12.9%
(158)

68.3%
(835)

5.6%
(69)

3.8%
(47)

1.3%
(16)

2.1%
(26)

5.2%
(63)

0.7%
(9)

Age > 50
19.8% (842)

12.2%
(103)

41.6%
(350)

4.2%
(35)

2.4%
(20)

0.2%
(2)

1.3%
(11)

37%
(313)

1%
(8)
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Table 2. The distribution of nonneoplastic smear results according to menopausal status (frequency analysis; percentage (number)).
Characteristics

N

NSI

BV

CS

AS

TV

AV

ASC-US

Menstrual 75%
(3188)

11.6%
(371)

72%
(2297)

5.9%
(188)

5.8%
(185)

1.1%
(36)

1.5%
(48)

1.2%
(39)

0.8%
(24)

Menopausal 25%
(1060)

13.2%
(140)

44%
(469)

4.6%
(49)

3.1%
(33)

0.2%
(2)

1.1%
(12)

32.5%
(344)

1%
(11)

Table 3. Comparison of intrauterine device (IUD) and oral contraceptive pill (OP) findings
(chi-square test; percentage (number)).
Characteristic

IUD 17.2% (730)

OP 7.8% (322)

P-value

NSI

71.6% (522)

81% (269)

0.0018

BV

7% (51)

2.7% (9)

<0.001

CS

7.3% (53)

3.9% (13)

<0.001

AS

4% (29)

0% (0)

<0.001

TV

1.8% (13)

1.5% (5)

0.2287

AV

0.5% (4)

0.6% (2)

0.5008

ASC-US

0.8% (6)

0.6% (2)

0.2480

Erosion

6.7% (49)

7.5% (25)

0.0088

Discharge

56% (408)

63.9% (212)

0.0144

age, the flora of the vagina is more susceptible to
inflammation. This shows the effects of sexual life on
smear results.
In comparing the smear results of women of
reproductive age with those who are in menopause, it
can be seen that NSI was predominant in both groups,
although it was more common in women of reproductive
age. Following in frequency were the NS results. In the
menopausal group, AV was markedly high. This result
is natural, given the effect of decreasing estrogen on
cervicovaginal tissue during menopause. In the menopausal
group, the vaginal microflora lacks lactobacilli due to the
deficiency of estrogen, which sets the stage for atrophic
vaginitis (9). Since almost half of the women over age 40
showed AV, local estrogen therapy, unless contraindicated,
can be suggested for this group to aid sexual activity. In
addition, in the menopausal group, ASC-US was found at a
higher rate than in the menstruating group (1% and 0.8%,
respectively). This result may be related to cytohormonal
changes in menopause. In both groups, the most common
cervical infections are BV and CS. Compared to other
infectious agents, BV and CS are also the most common

agents in all age groups. If we evaluate results according
to age groups, CS is predominant in both the age groups
of 0–20 and 20–40 years, whereas in the 40–50 group,
BV becomes more common. In the age group of those
over 50, the rates of BV and CS fall as low as 4.2%. CS
is most common in the younger age group. In the other
reproductive age groups, BV and CS rates are comparable,
and both rates decrease with age. In view of these results,
along with previous ones, it can be stated that smears are
valuable in the diagnosis of infectious pathologies such as
BV and CS (6).
In our study, the TV prevalence rate was found to be
1.4%, which was consistent with a previous study from
Iran, which reported a rate of 0.9%. Trichomonas vaginalis
is referred to as a sexually transmitted disease, and this
similarity in prevalence may be due to the comparable
developmental status and religion of the 2 countries, where
religious life inhibits the taking of multiple partners (10).
However, an epidemiologic study from Palestine reported
a prevalence rate of 18.2%, which is very high compared to
the above-mentioned studies (11). This reflects the effect of
developmental status on infectious diseases in countries.
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In the present study, smear results were compared
between 730 subjects who used an IUD and 322 who used
OPs. Results showed significantly higher degrees of NSI in
the OP group. Increased inflammation may be due to the
decrease in lactobacilli caused by the cytohormonal effects
of OP use on cervicovaginal flora (12).
The rate of BV was found to be significantly higher in
the IUD group than in the OP group, which is compatible
with the results of previous studies, which support the
relationship between IUDs and BV (13). Gardnerella
vaginalis is an anaerobic microorganism found in normal
flora. IUDs exert long-term contraceptive effects by
spreading copper in uterine secretions (14) and through
negative effects on lactobacilli. They may cause an increase
in anaerobic microorganisms such as Gardnerella vaginalis,
and hence the increase of BV (15,16).
Similarly, in the IUD group, the rate of CS was
significantly higher than in the OP group. In some
previous studies, the effect of OP use on vaginal flora was
emphasized, but it was not compared with the effect of
IUD use on vaginal flora. In our comparative study, the
relationship between BV, CS, and IUD use is very clear
(12), suggesting that the IUD may impair vaginal flora
more than OP use does (17) (Figures 1 and 2).

As shown in previous studies, there was a remarkable
rise in AS in the IUD group (17,18). AS colonization is
mostly seen in cases of long-term IUD usage (18). The
fact that AS was not diagnosed in non-IUD users in our
study is also compatible with this theory. In the absence
of symptoms, IUD removal or antibiotherapy is not
recommended, but if AS is determined through a Pap
smear, the patient should be reexamined for symptoms
(19,20).
In addition, when comparing the 2 groups with regard
to discharge and erosion, both symptoms were found at
significantly higher rates in the OP group. According to
our results, despite studies supporting the protective effect
of OP on vaginal flora (21), both OPs and IUDs produce
effects impairing vaginal flora, with the effect of IUDs
appearing to be stronger (17). There was no significant
difference between the IUD and OP groups in terms of AV,
TV, and ASC-US.
In conclusion, Pap smears can provide useful
information about infectious diseases that can occur in
the cervicovaginal region. These results reflect the fact
that IUDs disrupt vaginal flora more than OPs do. Studies
on this issue are limited, and population-based studies
confirmed with microbiologic tests are required.

Figure 1. Nonspecific inflammation in an OP user. Note
lactobacilli in background (conventional preparation, Pap 400×).

Figure 2. Shift in flora suggestive of bacterial vaginosis in an
IUD user. Note coccobacilli in the background (conventional
preparation, Pap 400×).
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